جست‌وجوی استاد و پژوهشگر

• Vascular Surgery
• Abdominal Aortic Aneurysm
• Endovascular Aneurysm Repair
• +۷ مورد دیگر

Sander ten Raa is a researcher in the Department of Surgery at Erasmus MC, Faculty of Medicine, with a strong focus on vascular surgery and abdominal aortic aneurysm (AAA) management. His research integrates clinical data, advanced imaging, and molecular profiling to improve patient outcomes following endovascular procedures. Institution: Erasmus MC School: Faculty of Medicine Department: Department of Surgery Role: Researcher His research interests center on the pathophysiology and clinical management of abdominal aortic aneurysms, particularly through endovascular aneurysm repair (EVAR). He investigates aneurysm growth dynamics using CT imaging, explores biomarkers via proteomics and metabolomics, and evaluates long-term outcomes of fenestrated and branched EVAR techniques. Additional areas include kidney graft implantation in complex vascular settings and sex-based disparities in AAA presentation. The recent publications reveal a consistent trend toward data-driven, translational research combining clinical follow-up with multi-omics analysis. There is a strong emphasis on identifying predictive biomarkers for aneurysm progression, optimizing surveillance protocols, and understanding post-intervention complications without endoleaks. His work frequently appears in high-impact journals such as the Journal of Vascular Surgery and American Journal of Transplantation . While no specific scientific awards are listed in the provided data, his collaborative network includes leading experts in cardiology, transplantation, and vascular surgery, suggesting recognition within the academic community. Dr. ten Raa has contributed to multiple peer-reviewed articles involving patient cohorts, systematic reviews, and biomarker discovery efforts. Although no formal advising or grant information is available, his involvement in multi-center studies implies participation in funded research initiatives. He is part of a dynamic surgical research team focused on innovation in endovascular therapies and transplant-related vascular complications.

Jay Panditمشاهده پروفایل

استاد بالینی

• Digital Medicine
• Wearable Technology in Healthcare
• Cardiovascular Monitoring
• +۳ مورد دیگر

Dr. Jay Pandit is the Director of Digital Medicine at the Department of Translational Medicine, SRTI. He holds a B.A. in Biology and Social Anthropology from Stanford University (2006), an M.D. in Cardiology from the University of California San Francisco (2010), and completed the Stanford Graduate School of Business LEAD Executive Program (2021). His research bridges medicine and technology, focusing on wearable devices for clinical outcomes, such as cuffless blood pressure monitoring and smart device integration. His work spans global health initiatives like the Shamba Maisha pilot study in Kenya to advancing telemedicine and precision medicine. Awards include the AMA Physicians of Tomorrow Award (2009) and multiple innovation accolades for digital health technologies. Publications highlight cardiovascular diagnostics, hypertension, and patient-centric healthcare frameworks. His leadership drives transformative health tech solutions, emphasizing clinical relevance and accessibility.

Bjørn Bendzمشاهده پروفایل

استاد

• Cardiology
• Acute Coronary Syndromes
• Percutaneous Coronary Intervention
• +۱۲ مورد دیگر

Bjørn Bendz is a Professor II at the Clinic for Cardiovascular and Pulmonary Diseases, Oslo University Hospital, and affiliated with the Faculty of Medicine at the University of Oslo. His role combines clinical cardiology with active research in acute coronary syndromes, interventional cardiology, and outcomes in elderly patients. Research Interests: His work focuses on invasive vs. conservative management strategies in elderly patients with acute coronary syndromes, percutaneous coronary intervention (PCI), cardiac imaging (including speckle tracking and strain analysis), inflammatory pathways in myocardial infarction (especially IL-6 inhibition), and rehabilitation post-PCI. He also investigates high-intensity interval training in heart transplant recipients and patient experiences in cardiac care. Publication Trends: His recent articles (2022–2024) show a strong emphasis on clinical trials, meta-analyses, and multicenter studies, particularly in geriatric cardiology and interventional outcomes. Key themes include the After Eighty trial, TAVI outcomes, IL-6 receptor inhibition (e.g., tocilizumab), and patient-centered outcomes such as medication adherence and quality of life. Scientific Contributions: He has contributed to major studies published in European Heart Journal , Lancet , JACC , and BMJ Open . His role often involves analyzing long-term outcomes, patient stratification, and inflammatory biomarkers in cardiovascular disease. Grants and Advising: While specific grants are not listed, his involvement in large multicenter trials (e.g., After Eighty, HITTS, ACASA-TAVI) suggests leadership in collaborative research. Though no direct students are named, his frequent co-authorship with junior researchers indicates mentorship and advising roles. Labs and Teams: He collaborates extensively with research groups at Oslo University Hospital, particularly in cardiology and imaging. He is part of teams investigating inflammatory mechanisms in MI, cardiac rehabilitation, and interventional outcomes, often working with experts in echocardiography, immunology, and geriatrics.

Per Medbøe Thorsbyمشاهده پروفایل

دانشیار

• Endocrinology
• Diabetes
• Hormone Diagnostics
• +۷ مورد دیگر

Per Medbøe Thorsby is an Associate Professor in the Department of Medical Biochemistry at the Faculty of Medicine, University of Oslo. He is medically responsible for the Hormone Laboratory at Aker Hospital, Oslo University Hospital, and actively engaged in clinical and research activities in endocrinology and metabolism. Research Interests: Diagnosis and management of endocrine diseases Diabetes and metabolic disorders Adrenal, thyroid, and pediatric endocrinology Gynecological endocrinology Anti-doping in sports Vitamin D and bone health Steroid hormone analysis using LC-MS/MS His recent publications (2023–2025) reflect a strong focus on endocrinology, clinical biochemistry, and metabolic health. Key themes include: Development and validation of advanced analytical methods (LC-MS/MS) for steroid and thyroid hormone measurement Investigations into vitamin D metabolism in pregnancy, children, and metabolic disease Cardiovascular and neurological effects of anabolic steroid use Autoimmune aspects of narcolepsy and related disorders Bone health in diabetes and rare metabolic conditions Scientific Awards and Recognition: No specific awards listed in the provided text. Advising and Grants: Course manager for laboratory courses in endocrinology since 2008 Teaches continuing medical education for doctors in diabetes and hormonal disorders Lectures for bioengineer students Leader of the 'Biochemical endocrinology and metabolism research group' at Oslo University Hospital Reviewer for multiple international journals since 2006 Expert for Norwegian Medicines Agency and EMA (2013–2020) Labs and Research Groups: Hormone Laboratory, Aker Hospital / Oslo University Hospital Biochemical Endocrinology and Metabolism Research Group, OUS

• Cardiology
• Interventional Cardiology
• Coronary Artery Disease
• +۳ مورد دیگر

Mariusz Tomaniak is a Researcher in the Department of Cardiology at Erasmus University Rotterdam, specializing in interventional cardiology and advanced coronary imaging techniques. His work bridges clinical cardiology with biomedical engineering to refine diagnostic and therapeutic approaches for coronary artery disease. His research focuses on fractional flow reserve (FFR) methodologies, intravascular imaging (particularly optical coherence tomography and near-infrared spectroscopy), and hemodynamic factors influencing plaque progression. Tomaniak investigates how wall shear stress affects lipid-rich plaque development and validates angiography-based FFR as a less invasive alternative to pressure-wire measurements. Analysis of his recent publications reveals a dominant trend toward multimodal imaging integration and angiography-derived physiological assessment, as evidenced by the FAST study series. These works demonstrate significant clinical impact through high citation counts (20+ Scopus citations for multiple papers) and widespread dissemination via 6+ news outlets and substantial social media engagement (22+ X posts, 1+ Facebook pages). Tomaniak maintains active collaborations within Erasmus MC's Cardiology department and international research networks, contributing to large-scale clinical trials that translate imaging insights into improved percutaneous coronary intervention outcomes.

Christine Berger Sprecherمشاهده پروفایل

مدرس

• Biochemistry
• Molecular Biology
• Biomedical Sciences
• +۳ مورد دیگر

Christine Berger Sprecher is a part-time Lecturer and Senior Scientist at the Department of Biochemistry, University of Zurich since 2013. She is affiliated with both the Faculty of Science and Faculty of Medicine, teaching modules such as BCH 201 (Biochemistry I) and practical courses in Biochemistry. Her research focuses on biochemical education, e-learning platforms (e.g., BLaTon/BLexon), and molecular mechanisms in infectious diseases. She holds a Ph.D. in Biochemistry (1997) and a diploma in higher education (2001), complemented by postdoctoral and teaching roles in Zurich's academic institutions. Her work bridges scientific research with educational innovation, addressing challenges in biochemistry instruction and clinical diagnostics. Educational Background: Bachelor’s/Master’s in Biochemistry (1988–1993), University of Zurich Ph.D. in Biochemistry (1993–1997), supervised by Prof. Hans Rudolf Bosshard Diploma in Higher Education (2001) Research Interests: Christine combines biochemical research with pedagogical advancements, particularly in e-learning solutions for science education. She explores metabolic pathways in viral infections (e.g., Epstein-Barr virus) and diagnostic methods for conditions like endometrial cancer. Her work emphasizes translational applications, such as improving post-transplant infection management and CAR-T cell therapies. Awards: No specific honors are listed, though her contributions to interdisciplinary education and clinical research are notable. Advising/Grants: No formal grants or advisee list provided, but her teaching roles suggest mentorship in academic and clinical settings. She collaborates with the Swiss Transplant Cohort Study on infection epidemiology. Labs/Teams: Active within the Department of Biochemistry, contributing to both research and educational initiatives at the University of Zurich.

Rita Pintoمشاهده پروفایل

استادیار مهمان

• Cardiovascular Disease
• Cardiac Rehabilitation
• Exercise Physiology
• +۴ مورد دیگر

Rita Pinto is a Visiting Assistant Professor at the Faculty of Medicine of the University of Lisbon (FMUL) and a researcher at the Cardiovascular Center of the University of Lisbon (CCUL@RISE). She coordinates the Cardiovascular Exercise and Rehabilitation Laboratory and the Physical Activity Unit at the Institute of Preventive Medicine and Public Health. Her academic roles include membership in the scientific advisory board of the RISE Laboratory and the EAPC Young Community Core Group of the European Society of Cardiology (2024-2026). Dr. Pinto holds a PhD in Physical Activity and Health (2019) from the Faculty of Human Kinetics (FMH-UL) and multiple advanced degrees in Exercise and Health, Sports Science, and Cardiac Rehabilitation. Her research focuses on cardiovascular disease, cardiac rehabilitation, exercise physiology, and physical activity promotion. She has published extensively in peer-reviewed journals and presented over 70 papers at international conferences. Her work emphasizes the integration of exercise science and clinical cardiology, particularly in improving patient outcomes through structured rehabilitation programs. She currently serves as Deputy Director of the National Program for the Promotion of Physical Activity (PNPAF) under the Portuguese Directorate-General for Health (DGS), advocating for evidence-based physical activity policies. Key research interests include the efficacy of cardiac rehabilitation phases (2 and 3), cardiopulmonary exercise testing, and the role of physical activity in managing conditions like heart failure and chronic thromboembolic pulmonary hypertension. Her studies often bridge clinical practice and population health, addressing gaps in guideline implementation and patient adherence to rehabilitation protocols.

• Cardiovascular Imaging
• Cardio-Oncology
• Heart Failure
• +۷ مورد دیگر

Dr. Davinder S. Jassal is a Full Professor in the Department of Internal Medicine, Department of Radiology, and Department of Physiology and Pathophysiology at the University of Manitoba, affiliated with the Rady Faculty of Health Sciences. He serves as Head of the Section of Cardiology and is the Principal Investigator of the Cardiovascular Imaging Laboratory at the Institute of Cardiovascular Sciences, St. Boniface Albrechtsen Research Centre. His educational background includes an MD from the University of Manitoba (1998), residency in Internal Medicine (1998–2001), Adult Cardiology training at Dalhousie University, and a clinical and research fellowship in Cardiac Imaging (echocardiography, CT, MRI) at Massachusetts General Hospital, Harvard Medical School. Dr. Jassal's research focuses on multimodality non-invasive cardiovascular imaging for assessing heart failure, particularly in high-risk populations such as women undergoing breast cancer chemotherapy. His work emphasizes translational applications in Cardio-Oncology , Women’s Heart Health , and Sudden Cardiac Death . Key research initiatives include the SHIELD-HF study (SGLT2 inhibitors for cardioprotection), the CANFLAX study (flax 'milk' for preventing chemotherapy-induced heart failure), and the EXACT 2.0 trial (aerobic exercise to mitigate anthracycline cardiotoxicity). His lab utilizes echocardiography, cardiac CT, and cardiac MRI to evaluate structural, electrical, and functional cardiac changes. No scientific awards were mentioned in the provided text. Dr. Jassal joined the University of Manitoba in 2006 as an Academic Clinician Scientist, dividing his time equally between clinical work in the Acute Cardiac Care Unit and cardiac imaging, and translational research. He leads a research team within the Cardiovascular Imaging Laboratory at St. Boniface Hospital, collaborating with technicians such as Mr. David YC Cheung. While specific grants are not detailed, his research program is actively investigating novel cardioprotective strategies in oncology settings, with implications for public health and agricultural innovation in Manitoba. The Cardiovascular Imaging Laboratory is a key component of his research infrastructure, supporting clinical trials and imaging-based translational studies focused on preventing chemotherapy-induced cardiotoxicity.

Martin G. Rodriguez-Porcelمشاهده پروفایل

استاد

• Molecular Imaging
• Cardiovascular Medicine
• Regenerative Medicine
• +۴ مورد دیگر

Martin G. Rodriguez-Porcel, MD is a Professor of Medicine and Consultant in the Department of Cardiovascular Medicine at Mayo Clinic. He holds joint appointments in the Division of Critical Care Cardiology and the Department of Physiology & Biomedical Engineering. His research focuses on molecular imaging strategies for cardiovascular therapies, atherosclerosis pathways, and vascular abnormalities in polycystic kidney disease (PKD). His work bridges clinical practice and translational research, aiming to improve patient outcomes in cardiology and nephrology. Education: MD, Universidad del Salvador Residency: Internal Medicine, Alton Ochsner Medical Foundation Fellowship: Cardiovascular Diseases, Mayo Clinic Postdoctoral Fellowship: Molecular Imaging at Stanford University Research Interests: Molecular imaging of cell therapies (e.g., stem cell tracking via PET/CT, optical imaging) Pathophysiology of vascular abnormalities in PKD using genomic and imaging tools Non-invasive assessment of atherosclerosis pathways Development of novel imaging modalities for clinical translation Awards: Recipient of the Discovery Science Award (2020-2022), Regenerative Medicine Minnesota Grants & Projects: National Heart, Lung, and Blood Institute-funded studies on stem cell fate, mitochondrial function, and oxidative stress Translational research in PKD vascular pathophysiology Labs & Affiliations: Member of the Cardiovascular Research Center and Physiology & Biomedical Engineering at Mayo Clinic Principal Investigator in the Robert M. and Billie Kelley Pirnie Translational PKD Center

• Biomedical Signal Processing
• Unobtrusive Sensing
• Medical Devices
• +۵ مورد دیگر

Esteban J. Pino is an Associate Professor at Universidad de Concepcion, Chile, actively engaged in research at the intersection of biomedical engineering and healthcare technology. His work focuses on developing innovative medical devices and signal processing techniques for clinical applications. His research interests span biomedical signal processing , unobtrusive sensing , and medical device development , with particular emphasis on respiratory monitoring, cardiac diagnostics, and pediatric health interventions. Utilizing advanced computational models and machine learning, his work bridges engineering solutions with real-world medical challenges. The recent publications highlight a strong trend in portable diagnostic systems , neural signal interpretation , and digital health frameworks for chronic disease management and early childhood development. These contributions reflect a multidisciplinary approach combining engineering, neuroscience, and clinical medicine. Dr. Pino serves as an Associate Editor for Connected Health in Frontiers in Digital Health , contributing to the peer-review and editorial process in his domain. He collaborates extensively across international research networks, as evidenced by co-authorship with researchers from diverse institutions. Though no formal advisees are listed, his editorial role and publication record suggest active mentorship and leadership in the academic community. His work is centered on practical, deployable healthcare technologies, particularly in low-resource or home-based settings, aiming to improve diagnostic accessibility and patient outcomes.

David Brownمشاهده پروفایل

استاد

• Pediatric Cardiology
• Congenital Heart Disease
• Single Ventricle Physiology
• +۷ مورد دیگر

Dr. David Brown is a prominent pediatric cardiologist affiliated with Harvard Medical School and Boston Children's Hospital, where he has completed all his clinical training and continues his research and clinical work. His expertise lies in congenital heart disease, particularly in single ventricle physiology, interstage care, and long-term outcomes following palliative surgeries. Undergraduate: Williams College (1989) Graduate: Bryn Mawr College (1991) Medical School: Harvard Medical School (1996) Internship, Residency, Fellowship: Boston Children’s Hospital Dr. Brown’s research focuses on improving outcomes in children with complex congenital heart defects. His work spans interstage mortality prediction , quality improvement initiatives , echocardiographic assessment , and family-centered care . He has played a key role in national collaborative networks such as the National Pediatric Cardiology Quality Improvement Collaborative (NPC-QIC) and the Pediatric Cardiac Critical Care Consortium (PC4), driving data-driven improvements in pediatric cardiovascular care. His recent publications reveal a strong emphasis on risk stratification models (e.g., NEONATE score), digoxin use in high-risk infants , exercise restrictions in bicuspid aortic valve patients , and health disparities in prenatal diagnosis and care . His interdisciplinary approach integrates clinical cardiology, epidemiology, and public health to address systemic challenges in pediatric heart disease management. While no formal awards are listed, his extensive publication record in top-tier journals such as Circulation , JACC , and Pediatric Cardiology reflects significant scientific contributions. He has also contributed to educational advancements in pediatric cardiology training, including fellowship boot camps and competency assessments. Research Leadership: NPC-QIC, PC4 Registry Key Topics: Single Ventricle, Fontan, Interstage Care, Aortic Stenosis, Pulmonary Valve Disease Methodologies: Observational Studies, Registry Linkage, Risk Modeling, Quality Improvement Dr. Brown mentors trainees and contributes to curriculum development, particularly in fellowship education. Although no specific lab or team is named, his collaborative work suggests leadership in multi-institutional research networks focused on enhancing survival and quality of life for children with congenital heart disease.

Aija Mača-Kalējaمشاهده پروفایل

استادیار

• Clinical Medicine
• Cardiology
• Internal Diseases
• +۲ مورد دیگر

Aija Mača-Kalēja is an Assistant Professor at the Department of Internal Diseases , Riga Stradins University. Her work focuses on cardiology , particularly in atrial fibrillation , sudden cardiac death , and myocarditis , contributing to clinical guidelines and device development. Director of research on defibrillation and antiarrhythmic therapies Active in emergency cardiac care and non-invasive diagnostics Her recent publications highlight advancements in automated external defibrillators and post-cardioversion drug efficacy . Collaborations span Latvian and European cardiology networks , including roles in the ESC Scientific Document Group . She has presented at conferences like the RSU International Research Conference and co-authored high-impact review articles .

Joana M. Ramisمشاهده پروفایل

مدرس ارشد

• Regenerative Medicine
• Cellular and Tissue Engineering
• Extracellular Vesicles
• +۶ مورد دیگر

Joana M. Ramis is a Senior Lecturer at the Department of Fundamental Biology and Health Sciences, Faculty of Health Sciences, University of the Balearic Islands (UIB). She holds a PhD in Biochemistry and Molecular Biology and has built a distinguished career in regenerative medicine and cellular engineering, with over 60 research articles, 3 patents, and leadership in 10 R&D projects as principal investigator. Bachelor in Pharmacy, University of Barcelona (1998) Bachelor in Biochemistry, University of the Balearic Islands (2002) PhD in Biochemistry and Molecular Biology, UIB (2003) Marie Curie Intra-European Fellowship, The Gurdon Institute, University of Cambridge (2004–2006) Her research focuses on cell-free regenerative medicine using extracellular vesicles derived from various cell types, aiming to develop novel therapies for tissue repair and clinical translation. She has pioneered work in scalable production, functional characterization, and therapeutic applications of extracellular vesicles in bone regeneration, wound healing, and autoimmune diseases. The analysis of her recent publications reveals a strong emphasis on translational regenerative medicine , with recurring themes in extracellular vesicle engineering , immunomodulation , biomarker discovery , and clinical standardization . Her work bridges molecular biology with biotechnological innovation, often exploring how vesicles can be optimized for targeted delivery and disease modification. She has received multiple recognitions from the Balearic Government for her excellence in teaching, research, and technology transfer: 3 teaching five-year periods recognized 3 research six-year periods recognized Remuneration complements for teaching stimulation, research activity, research excellence, and knowledge transfer Multiple prizes for scientific and entrepreneurial achievements Joana M. Ramis actively supervises PhD students and post-doctoral researchers, having directed 8 PhD theses. She has participated in 30 R&D projects and 21 industry contracts, reflecting strong collaboration between academia and biotech. She also co-founded a biotechnology company, Numat Biomedical S.L., where she served as R&D Director from 2009 to 2014. Her work continues to influence both academic research and clinical applications in regenerative medicine. She is a key contributor to the scientific community as a reviewer for international journals and remains deeply engaged in advancing the field through innovation, education, and technology transfer.

Sam M. Leeمشاهده پروفایل

دانشیار

• Pediatric Cardiology
• Exercise Physiology
• Congenital Heart Defects
• +۷ مورد دیگر

Sam M. Lee, M.D., is an Associate Professor in the Department of Pediatrics — Division of Cardiology at the University of Arkansas for Medical Sciences (UAMS), practicing primarily at Arkansas Children’s Hospital in Little Rock and the Jonesboro Clinic. He joined UAMS in 2019, becoming the first full-time pediatric cardiologist at the Jonesboro satellite location, expanding access to specialized cardiac care for children in northeast Arkansas. Research Interests: Dr. Lee's clinical and research focus centers on pediatric cardiology, with special emphasis on outpatient cardiology, exercise physiology, and improving exercise performance in athletic adolescents. His work bridges clinical care and translational research, particularly in evaluating cardiovascular function in high-risk pediatric populations. Publications Overview: His recent research includes studies on echocardiographic assessment of pulmonary hypertension in infants with bronchopulmonary dysplasia and the use of external compression therapy for Fontan patients. These contributions reflect a strong focus on non-invasive diagnostics, cardiovascular rehabilitation, and innovative supportive therapies in complex congenital heart disease. Professional Recognition: American Board of Pediatrics — Pediatric Cardiology Certification Member, American College of Cardiology Training and Affiliations: Dr. Lee completed his medical education at the Medical College of Georgia, residency at Loma Linda University College of Medicine, and fellowship at the Medical College of Virginia. He is actively involved in clinical care, teaching, and research, serving children with congenital heart defects, heart failure, arrhythmias, and valvular disease. Clinical Practice: He practices at Arkansas Children’s Hospital (Little Rock) and the ACH Jonesboro Clinic, offering echocardiography, electrocardiography, and comprehensive pediatric cardiac evaluations. He accepts new patients by referral and provides second opinions.

Ronald Maagمشاهده پروفایل

استادیار

• Non-invasive Cardiology
• Cardiovascular Disease Prevention
• Hypertension
• +۹ مورد دیگر

Ronald Maag, M.D., is an Assistant Professor in the Department of Medicine - Cardiology at Baylor College of Medicine, where he serves as Medical Director of the Baylor Heart Clinic in Houston, Texas. He is a board-certified non-invasive cardiologist with clinical and academic leadership responsibilities. Education: BS, The Ohio State University, Columbus, Ohio (2007) MD, Wright State University, Dayton, Ohio (2011) Residency, Penn State Hershey Medical Center, Hershey, Pennsylvania (2014) Fellowship, Penn State Hershey Medical Center, Hershey, Pennsylvania (2017) Dr. Maag specializes in non-invasive cardiology with expertise in hypertension, hyperlipidemia, coronary artery disease, sports cardiology, and cardiovascular disease prevention. He is highly skilled in cardiovascular imaging modalities, particularly echocardiography and nuclear cardiology. His clinical work is complemented by a strong commitment to medical education. His recent research, including a 2022 publication in Circulation: Genomic and Precision Medicine , explores patient and clinician perspectives on precision cardiology care, reflecting a growing interest in personalized cardiovascular risk management and implementation science. Scientific Awards: Excellence in Teaching Award for Cardiovascular Disease As a clinician-educator, Dr. Maag actively mentors medical students, internal medicine residents, and cardiology fellows. He is dedicated to training the next generation of physicians and enhancing clinical education within cardiology. While no specific grants are listed, his involvement in the HeartCare Study indicates participation in clinical research initiatives. He is affiliated with the Baylor Heart Clinic and contributes to patient care at the McNair Campus.